InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2023-07-27 00:00:00 ET · period of report 2023-07-25 · accession 0001209191-23-043516 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-27 2023-07-26 WGS White Karen Ann CHRO S - Sale+OE $7.41 -61 4,761 -1% -$452.01
D 2023-07-27 2023-07-25 WGS White Karen Ann CHRO M - OptEx — +137 4,822 +3% —
D 2023-07-27 2023-07-25 WGS White Karen Ann CHRO M - OptEx $0.00 -137 1,091 -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-07-26 S D 61 $7.41 4,761 D — —
2 Common Class A Common Stock 2023-07-25 M A 137 — 4,822 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Derivative Restricted Stock Unit 2023-07-25 M D 137 $0.00 1,091 D — · — to — 137 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.